Cargando…
Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder
We herein report a patient with a history of rheumatoid arthritis treated with methotrexate, which caused methotrexate-associated lymphoproliferative disorder and obstructive jaundice due to an enlarged lymph node. The obstructive jaundice was treated with endoscopic biliary stenting. A histopatholo...
Autores principales: | Eso, Yuji, Uza, Norimitsu, Shirakawa, Kotaro, Sawada, Kenji, Katsuragi, Kentaro, Matsuura, Minoru, Seno, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120836/ https://www.ncbi.nlm.nih.gov/pubmed/29526961 http://dx.doi.org/10.2169/internalmedicine.0557-17 |
Ejemplares similares
-
Brentuximab Vedotin
Publicado: (2012) -
Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies
por: Pincez, Thomas, et al.
Publicado: (2020) -
Brentuximab vedotin induced uveitis
por: Therssen, Stijn, et al.
Publicado: (2022) -
Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013) -
Brentuximab vedotin: axonal microtubule's Apollyon
por: Mariotto, S, et al.
Publicado: (2015)